INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 447m ago
House PTR47m ago
SEC 13F46m ago
Robinhood Chain46m ago

Results

79,798 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
6
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$144K
707 sh
Mar 10, 2026Mar 11, 2026
Page 1386 of 1995
← PrevNext →
traded Mar 10, 2026
+1d
SEC Form 4

Evidence

6
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Option exercise
M—
2,462 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

5
PK
Pilkington KyleCHIEF LEGAL OFFICER
SESSES AI Corp
Open-market sale · 10b5-1 plan
SELL$30K
25.0K sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

5
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Tax withholding
F$25K
136 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

5
JD
Jolley Julie DianeEVP of Home Health Operations
EHABEnhabit, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
2,793 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

5
HE
Ho EmilyChief Accounting Officer
SNOWSnowflake Inc.
Tax withholding
F$25K
139 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

5
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Tax withholding
F$15K
121 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC Form 4

Evidence

4
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$1.20M
6,630 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

2
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M$65K
2,500 sh
Mar 11, 2026Mar 11, 2026
traded Mar 11, 2026
+0dSEC Form 4

Evidence

1
JD
Jolley Julie DianeEVP of Home Health Operations
EHABEnhabit, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
2,793 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC Form 4

Evidence

0
FJ
Fesko JohnPRESIDENT, CHIEF BUS. OFFICER
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
1,774 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

0
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Mar 11, 2026Mar 11, 2026
traded Mar 11, 2026
+0dSEC Form 4

Evidence

0
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Grant or award · 10b5-1 plan
A—
1,774 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

0
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$163K
904 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

0
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Tax withholding · 10b5-1 plan
F$29K
495 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

0
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Tax withholding · 10b5-1 plan
F$101K
558 sh
Mar 9, 2026Mar 11, 2026
traded Mar 9, 2026
+2dSEC Form 4

Evidence

49
CA
Chi AlexDirector, CEO
CGBDCarlyle Secured Lending, Inc.
Open-market purchase
BUY$97K
9,000 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

47
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$229.05M
15.00M sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

47
WP
Warburg Pincus & Co.Director, 10% Owner
SHCSotera Health Co
Open-market sale
SELL$229.05M
15.00M sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

47
HJ
Hill JaimePresident, Building Materials
AMRZAmrize Ltd
Open-market purchase
BUY$179K
3,184 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

42
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Open-market sale
SELL$57K
5,145 sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

42
BA
Basha Leigh-AlexandraDirector
CBNACHAIN BRIDGE BANCORP INC
Open-market purchase
BUY$14K
400 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

39
VS
von Schuckmann StephanDirector, CEO
STSensata Technologies Holding plc
Open-market purchase
BUY$502K
15.2K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC Form 4

Evidence

38
GM
Goodwin William Carroll MurphyChief Legal & Strategy Officer
OKLOOklo Inc.
Open-market sale
SELL$160K
2,820 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

36
SJ
Schweiger Patrick JosephChief Technology Officer
OKLOOklo Inc.
Grant or award
A—
27.5K sh
Dec 22, 2025Mar 10, 2026
traded Dec 22, 2025
+78dSEC Form 4

Evidence

35
CJ
Carlson Michael JamesPresident, Managed Services
STEMSTEM, INC.
Open-market sale
SELL$23K
2,079 sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

35
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Open-market sale
SELL$15K
3,413 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

35
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$17K
5,100 sh
Mar 2, 2026Mar 10, 2026
traded Mar 2, 2026
+8dSEC Form 4

Evidence

35
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Open-market sale
SELL$2.15M
77.2K sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

35
PN
Potter Jason J. N.Director, President and CEO
GOGrocery Outlet Holding Corp.
Open-market sale
SELL$394K
67.4K sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

34
MB
Mookerji Suman B.S.V.P., CFO
DCODUCOMMUN INC /DE/
Open-market sale
SELL$1.03M
7,791 sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

33
April McClain DelaneyDDependent child
STESTERIS plc
Purchase
BUY$1,001 – $15KFeb 6, 2026Mar 10, 2026
traded Feb 6, 2026
+32dHouse PTR

Evidence

32
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale
SELL$244K
4,439 sh
Mar 10, 2026Mar 10, 2026
traded Mar 10, 2026
+0dSEC Form 4

Evidence

32
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Open-market sale
SELL$240K
4,438 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

32
April McClain DelaneyDDependent child
BROBROWN & BROWN, INC.
Partial sale
SELL$1,001 – $15KFeb 24, 2026Mar 10, 2026
traded Feb 24, 2026
+14dHouse PTR

Evidence

31
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
16.3K sh
Mar 1, 2026Mar 10, 2026
traded Mar 1, 2026
+9dSEC Form 4

Evidence

31
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Open-market sale
SELL$4,399
1,019 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

31
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale
SELL$3,878
896 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

31
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Open-market sale
SELL$10K
2,331 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence

31
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Open-market sale
SELL$1,297
296 sh
Mar 9, 2026Mar 10, 2026
traded Mar 9, 2026
+1dSEC Form 4

Evidence